Skip to nav Skip to content

Clinical Trial Search

8 Clinical Trials Found

Clinical Trial 23659

A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ARV-806 in Participants With KRAS G12D Mutated Advanced Solid Tumors
Disease Site: Any Site, Cervix, Colon, Corpus Uteri, Lung, Other Female Genital, Pancreas, Rectum
PI: Kim, Richard

Clinical Trial 23229

An Open-Label Phase 1/2a Clinical Trial to Evaluate the Safety, Immunogenicity, and Preliminary Efficacy of a Lentiviral Vector-Based Therapeutic Vaccine Against Human Papilloma Virus (Lenti-HPV-07) in Participants with HPV-Associated Oropharyngeal Squamous Cell Cancer or Cervical Cancer
Disease Site: Cervix, Head & Neck, Lip, Oral Cavity and Pharynx, Oropharynx
PI: Rabinowits, Guilherme

Clinical Trial 23697

A Phase 1/1b, Open-label, Multicenter, First-in-human Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of VVD-159642, a RAS-PI3KA Inhibitor, as a Single Agent and in Combination in Participants With Advanced Solid Tumors
Disease Site: Any Site, Breast, Cervix, Corpus Uteri, Esophagus, Lip, Oral Cavity and Pharynx, Lung, Melanoma, skin, Other Digestive Organ, Other Female Genital, Other Skin, Ovary, Pancreas, Prostate, Small Intestine, Stomach
PI: Haura, Eric

Clinical Trial 23645

A Phase 1 Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid Tumors
Disease Site: Any Site, Cervix, Corpus Uteri, Other Female Genital, Other Male Genital, Other Urinary, Ovary, Prostate, Urinary Bladder
PI: Park, Robin

Clinical Trial 23380

A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Autologous Logic-gated Tmod CAR T Protducts in Heterozygous HLA-A*02 Adult with Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Disease Site: Cervix, Colorectal, Lung, Other Female Genital, Ovary, Uterus
PI: Avila, Monica

Clinical Trial 23549

Disease Site: Anus, Any Site, Breast, Cervix, Colon, Esophagus, Kaposi's sarcoma, Lip, Oral Cavity and Pharynx, Lung, Other Digestive Organ, Other Endocrine System, Other Urinary, Ovary, Rectum, Urinary Bladder
PI: Saltos, Andreas

Clinical Trial 23143

Disease Site: Cervix, Other Female Genital, Ovary
PI: Coghill, Anna

Clinical Trial 23618

Disease Site: Cervix, Other Female Genital
PI: Avila, Monica